CAVHANZA vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CAVHANZA and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAVHANZA	SIROLIMUS
Rating	New	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	NILOTINIB	SIROLIMUS
Manufacturer	Flex Pharma	Apotex
Dosage forms	Tablet, orally disintegrating	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

cavhanza sirolimus

Rating

New

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

NILOTINIB

SIROLIMUS

Manufacturer

Flex Pharma

Apotex

Dosage forms

Tablet, orally disintegrating

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Cavhanza and Sirolimus?

Cavhanza contains Nilotinib, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.